Published in Br J Cancer on October 19, 2010
Elastin-derived peptides increase invasive capacities of lung cancer cells by post-transcriptional regulation of MMP-2 and uPA. Clin Exp Metastasis (2012) 0.86
Elastin-derived peptides are new regulators of insulin resistance development in mice. Diabetes (2013) 0.86
Tendon extracellular matrix damage, degradation and inflammation in response to in vitro overload exercise. J Orthop Res (2015) 0.82
The Extracellular Matrix in Epithelial Ovarian Cancer - A Piece of a Puzzle. Front Oncol (2015) 0.81
Monitoring the dynamics of Src activity in response to anti-invasive dasatinib treatment at a subcellular level using dual intravital imaging. Cell Adh Migr (2014) 0.78
Uncoupling of Elastin Complex Receptor during In Vitro Aging Is Related to Modifications in Its Intrinsic Sialidase Activity and the Subsequent Lactosylceramide Production. PLoS One (2015) 0.76
The Elastin Receptor Complex: A Unique Matricellular Receptor with High Anti-tumoral Potential. Front Pharmacol (2016) 0.75
The Histochemistry and Cell Biology omnium-gatherum: the year 2015 in review. Histochem Cell Biol (2016) 0.75
Extracellular matrix composition defines an ultra-high-risk group of neuroblastoma within the high-risk patient cohort. Br J Cancer (2016) 0.75
The elastin peptide (VGVAPG)3 induces the 3D reorganisation of PML-NBs and SC35 speckles architecture, and accelerates proliferation of fibroblasts and melanoma cells. Histochem Cell Biol (2014) 0.75
Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma. Ann Surg (1970) 12.72
The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer (1997) 5.01
The plasminogen activation system in tumor growth, invasion, and metastasis. Cell Mol Life Sci (2000) 3.91
Elastic fibres. J Cell Sci (2002) 3.66
Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases. Eur J Biochem (1997) 2.63
Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J Biol Chem (2000) 2.12
Matrix metalloproteinases in human melanoma. J Invest Dermatol (2000) 1.84
Experimental metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis (1999) 1.70
The cell surface: the stage for matrix metalloproteinase regulation of migration. Curr Opin Cell Biol (2002) 1.63
Role of matrix metalloproteinases in melanoma cell invasion. Biochimie (2005) 1.54
Matrix metalloproteinases in cancer invasion, metastasis and angiogenesis. Drug Discov Today (2001) 1.46
Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem Photobiol (2003) 1.41
RNA interference inhibition of matrix metalloproteinase-1 prevents melanoma metastasis by reducing tumor collagenase activity and angiogenesis. Cancer Res (2007) 1.39
Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br J Cancer (1999) 1.38
Gelatinase A activity directly modulates melanoma cell adhesion and spreading. EMBO J (1995) 1.34
Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis. Cancer Res (2002) 1.27
Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem (2000) 1.26
Elastin as a matrikine. Crit Rev Oncol Hematol (2004) 1.25
A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen. J Biol Chem (1999) 1.22
High expression levels of collagenase-1 and stromelysin-1 correlate with shorter disease-free survival in human metastatic melanoma. Int J Cancer (2002) 1.17
Matrix metalloproteinase-1 associates with intracellular organelles and confers resistance to lamin A/C degradation during apoptosis. Am J Pathol (2005) 1.14
Elastin-elastases and inflamm-aging. Curr Top Dev Biol (2007) 1.13
Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol (1996) 1.13
Bovine elastin and kappa-elastin secondary structure determination by optical spectroscopies. J Biol Chem (1995) 1.10
Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol (2002) 1.10
Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J Pathol (1998) 1.08
Membrane type-1 matrix metalloproteinase promotes human melanoma invasion and growth. J Invest Dermatol (2004) 1.06
Topical synthetic inhibitor of matrix metalloproteinases delays epidermal regeneration of human wounds. Exp Dermatol (2001) 1.00
Collagenase immunolocalization studies of cutaneous secondary melanomas. Br J Cancer (1980) 0.98
Control of melanoma progression by various matrikines from basement membrane macromolecules. Crit Rev Oncol Hematol (2004) 0.96
In vivo overexpression of tumstatin domains by tumor cells inhibits their invasive properties in a mouse melanoma model. Exp Cell Res (2004) 0.92
Locally generated VGVAPG and VAPG elastin-derived peptides amplify melanoma invasion via the galectin-3 receptor. Int J Cancer (2008) 0.92
Immunolocalisation studies of matrix metalloproteinases-1, -2 and -3 in human melanoma. Virchows Arch (1999) 0.90
Transforming growth factor-beta1 inhibits tumor growth in a mouse melanoma model by down-regulating the plasminogen activation system. Exp Cell Res (2003) 0.89
'Proteolytic switching': opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression. Br J Cancer (1999) 0.85
Elastin-derived peptides upregulate matrix metalloproteinase-2-mediated melanoma cell invasion through elastin-binding protein. J Invest Dermatol (2004) 0.84
Tumor cell interactions with elastin: implications for pulmonary metastasis. Am Rev Respir Dis (1989) 0.83
The plasminogen activation system in melanoma cell lines and in melanocytic lesions. Melanoma Res (1996) 0.82
Interaction between elastin and tumor cell lines with different metastatic potential; in vitro and in vivo studies. J Cancer Res Clin Oncol (1991) 0.80
The elastin connection and melanoma progression. Anticancer Res (2005) 0.80
Binding of some metastatic tumor cell lines to fibrous elastin and elastin peptides. Int J Cancer (1993) 0.79
Relationship of tumorigenic malignant melanomas to dermal elastin: an expression of tumor/stromal interaction that may be related to prognosis. Am J Dermatopathol (2002) 0.77
Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell (1996) 5.91
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A (1998) 1.69
Flavonoids extracted from fonio millet (Digitaria exilis) reveal potent antithyroid properties. Nutrition (1996) 1.45
The woman at risk for developing ovarian cancer. Gynecol Oncol (1979) 1.27
Conformational dependence of collagenase (matrix metalloproteinase-1) up-regulation by elastin peptides in cultured fibroblasts. J Biol Chem (2000) 1.26
Dermatofibrosarcoma protuberans: wide local excision vs. Mohs micrographic surgery. Cancer Treat Rev (2008) 1.18
Thrombospondin 1: a multifunctional protein implicated in the regulation of tumor growth. Crit Rev Oncol Hematol (2004) 1.13
External ATP triggers a biphasic activation process of a calcium-dependent K+ channel in cultured bovine aortic endothelial cells. Pflugers Arch (1988) 1.10
Oxidative status and malondialdehyde in beta-thalassaemia patients. Eur J Clin Invest (2002) 1.09
Molecular determinants of inactivation within the I-II linker of alpha1E (CaV2.3) calcium channels. Biophys J (2001) 1.08
Oscillatory activation of calcium-dependent potassium channels in HeLa cells induced by histamine H1 receptor stimulation: a single-channel study. J Membr Biol (1987) 1.07
CD47 update: a multifaceted actor in the tumour microenvironment of potential therapeutic interest. Br J Pharmacol (2012) 1.06
A specific tryptophan in the I-II linker is a key determinant of beta-subunit binding and modulation in Ca(V)2.3 calcium channels. Biophys J (2002) 1.05
Mutations in the EF-hand motif impair the inactivation of barium currents of the cardiac alpha1C channel. Biophys J (1998) 1.00
Non-transferrin-bound iron in myelodysplastic syndromes: a marker of ineffective erythropoiesis? Hematol J (2000) 1.00
Thrombospondin-1 C-terminal-derived peptide protects thyroid cells from ceramide-induced apoptosis through the adenylyl cyclase pathway. Int J Biochem Cell Biol (2006) 0.93
Membrane-bound iron contributes to oxidative damage of beta-thalassaemia intermedia erythrocytes. Br J Haematol (2001) 0.91
Contribution of cytosolic cysteine residues to the gating properties of the Kir2.1 inward rectifier. Biophys J (2003) 0.91
Metabolic indicators of oxidative stress correlate with haemichrome attachment to membrane, band 3 aggregation and erythrophagocytosis in beta-thalassaemia intermedia. Br J Haematol (1999) 0.90
Carbohydrate-deficient transferrin, a sensitive marker of chronic alcohol abuse, is highly influenced by body iron. Hepatology (1999) 0.90
Inhibition of NF-kappa B activation in vitro and in vivo: role of 26S proteasome. Methods Enzymol (1999) 0.89
Tissue inhibitor of metalloproteinase-1 promotes hematopoietic differentiation via caspase-3 upstream the MEKK1/MEK6/p38alpha pathway. Leukemia (2007) 0.87
Role of Repeat I in the fast inactivation kinetics of the Ca(V)2.3 channel. Biochim Biophys Acta (2001) 0.87
Cryotherapy in the treatment of keloids. J Drugs Dermatol (2006) 0.87
Non-transferrin-bound iron in alcohol abusers. Alcohol Clin Exp Res (2001) 0.86
IPG (inositolphosphate glycan) as a cellular signal for TGF-beta 1 modulation of chondrocyte cell cycle. J Cell Physiol (1993) 0.86
Hypotonic shock activates a maxi K+ channel in primary cultured proximal tubule cells. Am J Physiol (1990) 0.83
The C-terminal CD47/IAP-binding domain of thrombospondin-1 prevents camptothecin- and doxorubicin-induced apoptosis in human thyroid carcinoma cells. Biochim Biophys Acta (2006) 0.83
Nontransferrin-bound iron in transfused patients with sickle cell disease. Int J Lab Hematol (2011) 0.83
[MRI of portal cavernoma with biliary involvement]. J Radiol (2002) 0.81
TGFbeta1 effects on functional activity of porcine thyroid cells cultured in suspension. J Endocrinol (2002) 0.80
[Multiple involvements of LRP-1 receptor in tumor progression]. Pathol Biol (Paris) (2009) 0.80
Non-transferrin-bound iron, iron-related oxidative stress and lipid peroxidation in beta-thalassemia intermedia. Transfus Sci (2000) 0.80
Annexin A1 processing is associated with caspase-dependent apoptosis in BZR cells. FEBS Lett (2003) 0.80
Role of aspartate residues in Ca(2+) affinity and permeation of the distal ECaC1. Am J Physiol Cell Physiol (2002) 0.80
pH and external Ca(2+) regulation of a small conductance Cl(-) channel in kidney distal tubule. Biochim Biophys Acta (2000) 0.79
Elastokine-mediated up-regulation of MT1-MMP is triggered by nitric oxide in endothelial cells. Int J Biochem Cell Biol (2007) 0.78
[Experimental study on transcutaneous reabsorption and the possible effect of flumethasone pivalate on the hypophysis-adrenal gland axis]. Minerva Dermatol (1967) 0.78
State-dependent inhibition of inactivation-deficient Ca(V)1.2 and Ca(V)2.3 channels by mibefradil. J Membr Biol (2001) 0.78
Immunohistochemical study of thrombospondin and its receptors alpha root of beta 3 and CD36 in normal thyroid and in thyroid tumours. J Clin Pathol (1999) 0.77
Colon cancer: an epidemiological survey. Am J Dig Dis (1976) 0.77
The effects of melatonin on Ca(2+) homeostasis in endothelial cells. J Pineal Res (2002) 0.77
Transforming growth factor beta-1 up-regulates clusterin synthesis in thyroid epithelial cells. Exp Cell Res (1999) 0.77
[Incremental lower extremity CT venography, a simplified approach for the diagnosis of phlebitis in patients with pulmonary embolism]. J Radiol (2001) 0.77
[Effect of elastin peptides on the production of matrix metalloproteinase 2 by human skin fibroblasts in culture]. J Soc Biol (2001) 0.77
Targeting focal adhesion assembly by ethoxyfagaronine prevents lymphoblastic cell adhesion to fibronectin. Anal Cell Pathol (Amst) (2012) 0.77
Interleukin-1beta (IL-1beta) induces a crosstalk between cAMP and ceramide signaling pathways in thyroid epithelial cells. Biochimie (2005) 0.76
Red blood cell antioxidant and iron status in alcoholic and nonalcoholic cirrhosis. Eur J Clin Invest (2002) 0.76
Fixed charges of the heart muscle interstitium. Biophys J (1985) 0.75
[Quid. Alveolar microlithiasis]. J Radiol (2002) 0.75
Involvement of the ceramide signaling pathway in modulating the differentiated state of porcine thyroid cells. Lipids (2000) 0.75
[Imaging of intraductal papillary mucinous tumor of the pancreas: literature review]. J Radiol (2001) 0.75
[Nursing the patient in his own setting]. Infirm Can (1981) 0.75
Erythropoietin stimulates glycosylphosphatidylinositol hydrolysis in rat erythroid progenitor cells and inositolphosphate glycan modulates their proliferation. Cell Signal (1994) 0.75
Evidence for a TSH-controlled ectophosphotyrosine phosphatase in pig thyroid cultured cells. Biochem Biophys Res Commun (1996) 0.75
Purification and analysis of the neutral glycan moiety of glycosyl phosphatidylinositol from porcine thyroid cells. Biomed Chromatogr (1999) 0.75
Purification and characterization of phospholipase A2 inhibitory proteins from pig thyroid gland. FEBS Lett (1988) 0.75
[Angio-MRI of the lower limbs using the moving-bolus technic without subtraction: technical note]. J Radiol (1999) 0.75
[Imaging of the intrahepatic biliary tree with thick slice MR cholangiography]. J Radiol (2001) 0.75
[New radiotherapy techniques for non-small-cell lung cancer]. Rev Pneumol Clin (2004) 0.75
Partial characterization of a glycosylphosphatidyl-inositol (GPI) in porcine thyroid cultured cells. Biochimie (1993) 0.75
Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporine. Transplant Proc (2003) 0.75
Glycosyl phosphatidylinositol (GPI)/inositolphosphate glycan (IPG): an intracellular signalling system involved in the control of thyroid cell proliferation. Biochimie (1998) 0.75
[Computed tomography study of the sigmoid colon: discriminating diagnostic criteria and interobserver correlations]. J Radiol (1999) 0.75
[Fibrous tissue(s): a key for lesion characterization in digestive diseases]. J Radiol (2002) 0.75
[Pneumobilia and MRCP: value of sagittal view]. J Radiol (2002) 0.75
[Quid? Capillary leak syndrome]. J Radiol (2001) 0.75
[Diffuse pulmonary lymphangiomatosis in a young adult]. Rev Mal Respir (2001) 0.75
Antibiotic therapy of transaxillary augmentation mammoplasty. In Vivo (2009) 0.75
[Quid?]. J Radiol (2000) 0.75
TSH-induced differentiated functions correlate with enhancement of phosphotyrosine phosphatase activity in thyroid cells. Effect of phorbol 12-myristate 13-acetate. J Endocrinol (2001) 0.75
Number of mast cells in the Harderian gland of the lizard Podarcis sicula sicula (Raf): the annual cycle and its relation to environmental factors and estradiol administration. Gen Comp Endocrinol (1997) 0.75
Different phosphorylated forms of inositolphosphate glycan could be involved in the transforming growth factor-beta 1 (TGF-beta 1) signalling pathway. Cell Signal (1994) 0.75
[Massive bone destruction: an atypical sign of orbital lymphoma]. J Fr Ophtalmol (1998) 0.75
Interleukin 1 beta (IL-1 beta) action in porcine thyroid cells involves the ceramide signalling pathway. Cytokine (2001) 0.75
Chicken GABA(A) receptor beta4 subunits form robust homomeric GABA-gated channels in Xenopus oocytes. Eur J Pharmacol (1998) 0.75
[Modifications of protein kinase C activity and phosphorylation of lipocortin I in cultures of pig thyroid cells]. Reprod Nutr Dev (1990) 0.75